Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of Psychiatry and Neuroscience

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPau CeladaMPM. Victoria PuigMAMercè Amargós‐Bosch

Discussion

Loading...

Member takes

Overview

Research shows SSRIs affect serotonin levels in depression patients, highlighting the importance of 5-HT receptors.

Key Points

  • The blockade of 5-HT 2A receptors may enhance the benefits of SSRIs in treating depression, improving clinical outcomes.
  • SSRIs work by blocking serotonin reuptake but require weeks to take effect due to adaptive mechanisms in the brain.
  • Interventions that include 5-HT receptor antagonists, such as atypical antipsychotics, can improve treatment for resistant depression.
  • Prefrontal cortex neurons enriched with 5-HT 2A receptors play a critical role in the effectiveness of SSRIs in depression management.

Cite This Study

Celada et al. (2004) studied this question.

synapsesocial.com/papers/68c19aad9b7b07f3a061c4ffhttps://doi.org/10.1139/jpn.0427
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex1993 · 190 citations
  2. 2Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-1006352000 · 643 citations
  3. 3Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors2001 · 68 citations